ranibizumab · Medicine question

Has the safety and efficacy of ranibizumab (Lucentis) been established in children under 18 for conditions other than retinopathy of prematurity?

Name: Has the safety and efficacy of ranibizumab (Lucentis) been established in children under 18 for conditions other than retinopathy of prematurity?
Published: 2026-11-08T01:59:41.053Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

The safety and efficacy of ranibizumab (Lucentis) have not been established in children and adolescents under 18 for indications other than retinopathy of prematurity.

Sources for this answer

Lucentis 10 mg/ml solution for injectionNovartis Pharmaceuticals UK Ltd · emc · SmPC §4.2 Posology and method of administration · Version 33Document updated 31 July 2023

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about ranibizumab